Strut Health vs. MangoRx: Ingredients, Pricing, and Regulatory Context
A regulatory letter should not be exaggerated, and it should not be hidden. The fair comparison separates ED products from the letter’s GLP-1 subject while still asking what the company’s marketing history says about claim discipline.
In this guide
- The at-a-glance verdict
- Product and ingredient comparison
- What the FDA warning letter does—and does not say
- Pricing and refill structure
- Comparing evidence and claim discipline
- Clinical process, support, and pharmacy questions
- Who should choose which
- A fair comparison checklist
- How we reviewed it
- Verification checklist
- Frequently asked questions
The at-a-glance verdict
| Category | Strut Health | MangoRx |
|---|---|---|
| Catalog | Combination products plus sildenafil and tadalafil | Sildenafil/tadalafil compounds and a dual-PDE5 product |
| Pricing | Varies by product and strength | $75/$150/$225 main pack tiers |
| Subscription | Default recurring model on many products | One-time or 10% subscription discount |
| Regulatory context | 2026 FDA warning letter about GLP-1 marketing | No equivalent letter identified in this review |
| Best fit | Broader menu and ongoing model | Simpler quantity selection |
MangoRx wins on initial pricing visibility. Strut wins on breadth and the availability of simpler ED options. Neither should be selected because of bold onset or “connection” language.
Product and ingredient comparison
Strut lists Super Strut combinations in different strengths and also offers sildenafil and tadalafil products. Its formulas may include tadalafil, vardenafil, apomorphine, and oxytocin depending on the selected treatment.
MangoRx lists sildenafil + L-arginine + oxytocin, tadalafil + L-arginine + oxytocin, and MangoMax containing sildenafil + tadalafil. The pack structure is easier to understand, but exact add-on doses should still be disclosed.
Strut’s ability to offer a simpler single-ingredient route is an advantage for treatment-naive patients. MangoRx’s standardized flavor and pack sizes may be more convenient for shoppers who already decided on a compound.
What the FDA warning letter does—and does not say
FDA issued warning letter 721448 to Strut Health in February 2026. The letter challenged claims involving compounded semaglutide and tirzepatide, including representations about effectiveness, safety, and equivalence. It did not make a specific finding that Super Strut or another ED formula was adulterated, ineffective, or unsafe.
The letter still matters because a provider’s company-wide claim discipline is relevant to consumer trust. Readers should see it prominently and accurately, not buried in fine print or stretched into a claim the agency did not make.
MangoRx should be judged by the same principle. Its own onset, oxytocin, L-arginine, and extended-release claims require product-specific substantiation even without a public warning letter.
Pricing and refill structure
MangoRx’s main page lists six tablets for $75, twelve for $150, and eighteen for $225, with ten percent off Subscribe & Save. The 25-day refill cadence can produce more charges per year than a monthly plan.
Strut pricing depends on product, strength, and subscription. The public pages should be checked at the point of order because starting prices can hide differences in quantity and formula.
For both, calculate annual cost at actual use. A subscription discount does not create value if doses accumulate. Include the cost of switching formulas after side effects or inadequate response.
Comparing evidence and claim discipline
Both providers lean on the idea that combining vascular and central ingredients addresses more of sexual response. That is a rationale, not proof of superior outcomes.
Oxytocin claims are particularly weak. Human evidence does not establish a predictable improvement in intimacy or male ED from adding it to these products. L-arginine has some human ED data at gram-level doses, but MangoRx should disclose the amount before those studies are applied.
Apomorphine has older ED trial evidence and important risks. Multiple PDE5 inhibitors create overlap. The exact finished products remain compounded and not FDA-approved.
Clinical process, support, and pharmacy questions
Both services use online intake and clinician review. Compare how quickly a named prescriber responds, whether live communication is available, and whether follow-up is included after the first shipment.
MangoRx provides general information about a Texas compounding pharmacy network and accreditations. Strut should identify the dispensing pharmacy for the selected state and product. Accreditation is a quality signal, not approval of efficacy claims.
Test cancellation and support channels before enrolling. A provider’s response to a pricing question can be more informative than its testimonials.
Who should choose which
Strut may fit someone who values a broader catalog, wants the possibility of standard sildenafil or tadalafil, and accepts an ongoing subscription model after reading the regulatory disclosure.
MangoRx may fit someone who wants visible one-time pack pricing and a flavored dissolving product. It is less attractive for someone uncomfortable with a 25-day refill cadence or unquantified add-on ingredients.
Patients who prioritize the cleanest evidence and lowest complexity should compare both with a conventional generic prescription.
A fair comparison checklist
- What exact ingredients and doses will be dispensed?
- Can I order once without automatic renewal?
- What is the true annual number of charges?
- Which pharmacy will dispense in my state?
- What evidence supports the exact product’s onset and benefit claims?
- What happened after Strut’s FDA warning letter, and were claims revised?
- Can I switch to a simpler single-ingredient treatment?
Strut Health
Strut offers Super Strut combination products plus sildenafil and tadalafil. Its 2026 FDA warning letter concerned GLP-1 marketing, not an ED-product finding, but it remains relevant regulatory context.
Check Strut HealthPaid provider link
Pricing, availability, formula, eligibility, and prescribing can change. The provider—not EdClinic—determines whether treatment is appropriate.
MangoRx
MangoRx lists sildenafil- and tadalafil-based compounded tablets with L-arginine and oxytocin, plus a dual-PDE5 product. Verify formula, quantity, and the 25-day refill cadence.
Check MangoRxPaid provider link
Pricing, availability, formula, eligibility, and prescribing can change. The provider—not EdClinic—determines whether treatment is appropriate.
How EdClinic evaluated Strut Health vs. MangoRx
We treated the public website as a claim set, not as proof. The review records what the provider currently displays, then separates four questions that sales pages often blend together: Is the active ingredient familiar? Is the finished product FDA-approved? Is the exact dose and route supported by evidence? Are the commercial terms clear enough to calculate a real annual cost?
We also looked for the identity or description of the prescribing group and dispensing pharmacy, the sequence of intake and payment, whether a live visit is required, what happens if the clinician declines treatment, shipping expectations, cancellation language, refill cadence, and whether a customer can choose a local pharmacy. A polished intake is useful, but it is not a substitute for those details.
Finally, we checked each provider against the same medical baseline. Sildenafil, tadalafil, and vardenafil are PDE5 inhibitors with nitrate and riociguat contraindications, blood-pressure cautions, interaction concerns, and urgent warnings for prolonged erection and sudden vision or hearing loss. Combining ingredients can increase uncertainty even when each ingredient is individually familiar. The safest review is therefore not the one with the most enthusiastic product description; it is the one that gives readers enough information to discuss a specific prescription with a licensed clinician.
Build a verification record before enrolling
Save a copy of the product page, intake summary, checkout total, subscription terms, prescription directions, pharmacy label, and cancellation instructions. Telehealth funnels change quickly, and several providers use more than one landing page. A dated screenshot can resolve whether a later charge, quantity, or formula matches what was shown when you enrolled.
On the medical side, prepare a complete list of prescriptions, over-the-counter drugs, supplements, nitrates or recreational nitrites, blood-pressure medicines, alpha blockers, cardiovascular diagnoses, kidney or liver problems, and prior ED treatments. Note the exact dose, timing, food, alcohol, benefit, and side effects from anything you tried before. “It did not work” gives a prescriber much less information than a short treatment record.
After treatment starts, document response without repeatedly testing a serious adverse effect. Contact the prescriber for persistent dizziness, severe headache, troublesome nausea, unusual sedation, or a product that is consistently ineffective. Seek urgent care for chest pain, fainting, sudden vision or hearing change, or an erection lasting more than four hours.
Frequently asked questions
Was Strut’s FDA warning letter about ED medication?
No. It concerned marketing claims for compounded semaglutide and tirzepatide. It is regulatory context, not an ED-product violation finding.
Which provider has clearer prices?
MangoRx’s main pack tiers are easier to see. Strut pricing varies by product and strength.
Which provider offers one-time orders?
MangoRx displays one-time purchasing alongside a subscription discount. Confirm current terms.
Are their compounded formulas FDA-approved?
No. The finished compounded products are not FDA-approved.
Sources and review basis
- Strut Health men’s sexual-health catalog — official site Accessed July 17, 2026.
- Super Strut product page — official site Accessed July 17, 2026.
- FDA Warning Letter 721448 to Strut Health — FDA Accessed July 17, 2026.
- MangoRx erectile-function products — official site Accessed July 17, 2026.
- MangoRx frequently asked questions — official site Accessed July 17, 2026.
- Understanding the Risks of Compounded Drugs — FDA Accessed July 17, 2026.
Provider details and prices were checked against public pages on the date shown. Checkout screens, state availability, prescriptions, pharmacy labels, and promotions can differ. Medical information is general and not personal advice.